BioMimir Selected for Prestigious MedTech Innovator 2025 Accelerator Cohort
— One of 65 startups chosen from nearly 1,500 global applicants —
— Selected to participate in the world’s leading medtech accelerator —
Sherbrooke, QC, Canada – June 5, 2025 – BioMimir, a medical device company focused on regenerative medicine, announced today that it has been selected to join the MedTech Innovator 2025 Accelerator Cohort. BioMimir is one of only 65 companies—representing the top 4% of nearly 1,500 global applicants—chosen for this year’s program.
MedTech Innovator (MTI) is the world’s largest accelerator for medical technology startups. The highly competitive four-month program provides participants with world-class mentorship, strategic guidance, and access to a robust network of investors, providers, payers, manufacturers, and industry experts.
“We are honored and excited to join this year’s MedTech Innovator cohort,” said D. Fiona Simpson, CEO of BioMimir. “This opportunity gives us a powerful platform to validate our technology, build key partnerships, and accelerate our path to market.”
BioMimir was selected based on its innovative approach to affordable, accessible regenerative medicine, its potential to treat a wide variety of acute and chronic wounds, and its alignment with MTI’s mission to improve patient care through transformative technology.
Throughout the program, cohort companies will present at major industry events including The MedTech Conference powered by AdvaMed (October 5–8 in San Diego) and/or the MedTech Strategist Innovation Summit (November 19–21 in San Diego), where they will compete for a share of $800,000 in non-dilutive funding.
About BioMimir
BioMimir is a regenerative medicine company that designs and manufactures biomimetic polymers that prevent scar during wound healing. Our proof of concept is, MatriFlex, a bioresorbable, liquid to solid skin substitute. We create affordable, accessible regenerative medicine solutions that are deployable globally.
BioMimir was founded by Dr. Fiona Simpson, Dr. Elle Edin and Benjamin Yam in 2021 in Montreal, QC, Canada.
About MedTech Innovator
MedTech Innovator is the world’s largest accelerator of medical device, digital health, and diagnostic companies. Its mission is to improve human health by accelerating the growth of companies transforming patient care. MTI has been a catalyst for groundbreaking healthcare solutions, sourcing nearly 14,000 applicants and fostering the growth of over 700 graduates. Alumni have collectively raised $10 billion in follow-on funding and introduced 400+ products to the market, improving the health of millions worldwide. For more information about MedTech Innovator, its annual programs, portfolio of industry-leading startups, and insights on trends, visit MTI’s website, follow them on LinkedIn, and subscribe to its monthly newsletter.
Media Contact:
Dr. Fiona Simpson
Chief Executive Officer